Literature DB >> 26274789

Should criteria for inclusion in cancer clinical trials be expanded?

David E Gerber1,2, Sandi L Pruitt2,3, Ethan A Halm2,3,4.   

Abstract

Entities:  

Keywords:  accrual; cancer; clinical trials; eligibility; enrollment; exclusion criteria

Mesh：

Year:  2015        PMID： 26274789      PMCID： PMC4838010          DOI： 10.2217/cer.15.27

Source DB:  PubMed          Journal:  J Comp Eff Res        ISSN： 2042-6305            Impact factor:   1.744


× No keyword cloud information.
  14 in total

1.  Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.

Authors:  Andrew L Laccetti; Sandi L Pruitt; Lei Xuan; Ethan A Halm; David E Gerber
Journal:  J Natl Cancer Inst       Date:  2015-02-09       Impact factor: 13.506

2.  Provider roles in the recruitment of underrepresented populations to cancer clinical trials.

Authors:  Mollie W Howerton; M Chris Gibbons; Charles R Baffi; Tiffany L Gary; Gabriel Y Lai; Shari Bolen; Jon Tilburt; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass; Jean G Ford
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

3.  Identification of cancer care and protocol characteristics associated with recruitment in breast cancer clinical trials.

Authors:  Julie Lemieux; Pamela J Goodwin; Kathleen I Pritchard; Karen A Gelmon; Louise J Bordeleau; Thierry Duchesne; Stéphanie Camden; Caroline H Speers
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

4.  Impact of prior cancer on eligibility for lung cancer clinical trials.

Authors:  David E Gerber; Andrew L Laccetti; Lei Xuan; Ethan A Halm; Sandi L Pruitt
Journal:  J Natl Cancer Inst       Date:  2014-09-24       Impact factor: 13.506

Review 5.  Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.

Authors:  Harriette G C Van Spall; Andrew Toren; Alex Kiss; Robert A Fowler
Journal:  JAMA       Date:  2007-03-21       Impact factor: 56.272

Review 6.  Barriers to participation in randomised controlled trials: a systematic review.

Authors:  S Ross; A Grant; C Counsell; W Gillespie; I Russell; R Prescott
Journal:  J Clin Epidemiol       Date:  1999-12       Impact factor: 6.437

7.  Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

Authors:  P N Lara; R Higdon; N Lim; K Kwan; M Tanaka; D H Lau; T Wun; J Welborn; F J Meyers; S Christensen; R O'Donnell; C Richman; S A Scudder; J Tuscano; D R Gandara; K S Lam
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

8.  Cancer patient accessions into clinical trials: a pilot investigation into some patient and physician determinants of entry.

Authors:  J McCusker; A Wax; J M Bennett
Journal:  Am J Clin Oncol       Date:  1982-04       Impact factor: 2.339

9.  Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure.

Authors:  Frederick A Masoudi; Edward P Havranek; Pam Wolfe; Cary P Gross; Saif S Rathore; John F Steiner; Diana L Ordin; Harlan M Krumholz
Journal:  Am Heart J       Date:  2003-08       Impact factor: 4.749

10.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272
View more
  20 in total

1.  Conceptual Model for Accrual to Cancer Clinical Trials.

Authors:  Simon J Craddock Lee; Caitlin C Murphy; Ann M Geiger; David E Gerber; John V Cox; Rasmi Nair; Celette Sugg Skinner
Journal:  J Clin Oncol       Date:  2019-06-05       Impact factor: 44.544

2.  The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies.

Authors:  A Statler; T Radivoyevitch; C Siebenaller; A T Gerds; M Kalaycio; E Kodish; S Mukherjee; C Cheng; M A Sekeres
Journal:  Leukemia       Date:  2016-12-07       Impact factor: 11.528

3.  Acute myeloid leukemia therapy and the chosen people.

Authors:  E Estey; R P Gale
Journal:  Leukemia       Date:  2016-11-11       Impact factor: 11.528

4.  Are clinical trial eligibility criteria an accurate reflection of a real-world population of advanced non-small-cell lung cancer patients?

Authors:  K Al-Baimani; H Jonker; T Zhang; G D Goss; S A Laurie; G Nicholas; P Wheatley-Price
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

5.  Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.

Authors:  Sandra Garcia; Ajit Bisen; Jingsheng Yan; Xian-Jin Xie; Suresh Ramalingam; Joan H Schiller; David H Johnson; David E Gerber
Journal:  J Thorac Oncol       Date:  2017-08-09       Impact factor: 15.609

6.  Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer: An Initial Report From the Surveillance, Epidemiology, and End Results Program.

Authors:  Caitlin C Murphy; David E Gerber; Sandi L Pruitt
Journal:  JAMA Oncol       Date:  2018-06-01       Impact factor: 31.777

Review 7.  Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.

Authors:  D Shepshelovich; H Goldvaser; L Wang; A R Abdul Razak; P L Bedard
Journal:  Invest New Drugs       Date:  2017-09-14       Impact factor: 3.850

8.  Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Authors:  I Stukalin; J C Wells; J Graham; T Yuasa; B Beuselinck; C Kollmansberger; D S Ernst; N Agarwal; T Le; F Donskov; A R Hansen; G A Bjarnason; S Srinivas; L A Wood; A S Alva; R Kanesvaran; S Y F Fu; I D Davis; T K Choueiri; D Y C Heng
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

9.  Tracking the Nonenrolled: Lung Cancer Screening Patterns Among Individuals not Accrued to a Clinical Trial.

Authors:  David E Gerber; Heidi A Hamann; Claudia Chavez; Olivia Dorsey; Noel O Santini; Travis Browning; Cristhiaan D Ochoa; Joyce Adesina; Vijaya Subbu Natchimuthu; Eric Steen; Hong Zhu; Simon J Craddock Lee
Journal:  Clin Lung Cancer       Date:  2020-02-26       Impact factor: 4.785

10.  Impact of prior cancer on outcomes in nasopharyngeal carcinoma.

Authors:  Huaqiang Zhou; Yaxiong Zhang; Jiaqing Liu; Wenfeng Fang; Yunpeng Yang; Shaodong Hong; Gang Chen; Shen Zhao; Jiayi Shen; Wei Xian; Zhonghan Zhang; Xi Chen; Hongyun Zhao; Yan Huang; Li Zhang
Journal:  Ann Transl Med       Date:  2019-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.